Multifunctioning pH-responsive nanoparticles from hierarchical self-assembly of polymer brush for cancer drug delivery

AIChE Journal

Volumn 54, Issue 11, 2008, Pages 2979-2989

  Shen, Youqing ^a   Zhan, Yihong ^a   Tang, Jianbin ^a   Xu, Peisheng ^a   Johnson, Patrick A ^a   Radosz, Maciej ^a   Van Kirk, Edward A ^b   Murdoch, William J ^b  

^a UNIVERSITY OF WYOMING   (United States)

^b UNIVERSITY OF WYOMING   (United States)

Author keywords

Drug delivery; Nanoparticles; pH sensitive; Polymer brush; Self assembly

Indexed keywords

CAPROLACTONE; CELLULAR INTERNALIZATIONS; CELLULAR UPTAKES; CYTOSOL; CYTOSOLIC; DRUG CARRIERS; DRUG RELEASES; ETHYL METHACRYLATES; INTRACELLULAR COMPARTMENTS; LYSOSOMAL MEMBRANES; MIDDLE LAYERS; OUTER LAYERS; PHYSIOLOGICAL PH; POLYMER BRUSH; POLYMER BRUSHES; POLYMER NANO PARTICLES; POSITIVELY CHARGED; SOLID TUMORS;

ABS RESINS; ACIDS; BRUSHES; CELL MEMBRANES; CIVIL AVIATION; DRUG DELIVERY; ETHYLENE GLYCOL; GLYCOLS; NANOPARTICLES; NANOSTRUCTURES; PH; PH EFFECTS; POLYETHYLENE GLYCOLS; POLYETHYLENE OXIDES; POLYMERS; SELF ASSEMBLY;

NANOSTRUCTURED MATERIALS;

EID: 55749102507     PISSN: 00011541     EISSN: 15475905     Source Type: Journal    
DOI: 10.1002/aic.11600     Document Type: Article

References (60)

1. Sinha R, Kim GJ, Nie S, Shin DM. Nanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug delivery. Mol Cancer Ther. 2006:5:1909-1917.
2. Brannon-Peppas L, Blanchette JO. Nanoparticle and targeted systems for cancer therapy, Adv Drug Deliv Rev. 2004;56;1649-1659.
3. van Vlerken LE, Amiji MM. Multi-functional polymeric nanoparticles for tumor-targeted drug delivery. Expert Opin Drug Deliv. 2006;3:205-216.
4. Yih TC, Al-Fandi M. Engineered nanoparticles as precise drug delivery systems. J Cell Biochem. 2006:97:1184-1190.
5. Sutton D, Nasongkla N, Blanco E, Gao J. Functionalized micellar systems for cancer targeted drug delivery. Pharm Res. 2007;24:1029-1046.
6. Rapoport N. Physical stimuli-responsive polymeric micelles for anticancer drug delivery. Prog Polym Sci. 2007;32;962-990.
7. Kwon GS. Diblock copolymer nanoparticles for drug delivery. Crit Rev Ther Drug. 1998;15:481-512.
8. Kataoka K, Harada A, Nagasaki Y. Block copolymer micelles for drug delivery: design, characterization and biological significance. Adv Drug Deliv Rev. 2001;47:113-131.
9. Brigger T, Dubernet C, Couvreur P. Nanoparticles in cancer therapy and diagnosis. Adv Drug Deliv Rev. 2002:54:631-651.
10. Moghimi SM, Hunter AC, Murray JC. Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol Rev. 2001;53;283-318.
11. Maeda H, Seymour LW, Miyamoto Y. Conjugates of anticancer agents and polymers: advantages of macromolecular therapeutics in vivo. Bioconjug Chem. 1992:3:351-362.
12. Jain RK. Delivery of molecular medicine to solid tumors: lessons from in vivo imaging of gene expression and function. J. Control. Release. 2001;74;7-25.
13. Yokoyama M, Okano T, Sakurai Y, Suwa S, Kataoka K. Introduction of cisplatin into polymeric micelle. J. Control. Release. 1996; 39: 351-356.
14. Uchino H, Matsumura Y, Negishi T, Koizumi F, Hayashi T, Honda T, Nishiyama N, Kataoka K, Naito S, Kakizoe T. Cisplatin-incorporating polymeric micelles (NC-6004) can reduce nephrotoxicity and neurotoxicity of cisplatin in rats. Br J Cancer. 2005;93:678-687.
15. Xu P, Van Kirk EA, Li S, Murdoch WJ, Ren J, Hussain MD, Radosz. M, Shen Y. Highly stable core-surface-crosslinked nanoparticles as cisplatin carriers for cancer chemotherapy. Colloi Surf B: Biointerf. 2006:48:50-57.
16. Nishiyama N, Okazaki S, Cabrai H, Miyamoto M, Kato Y, Sugiyama Y, Nishio K, Matsumura Y, Kataoka K. Novel cisplatinincorporated polymeric micelles can eradicate solid tumors in mice. Cancer Res. 2003:63:8977-8983.
17. Xu P, Van Kirk EA, Murdoch WJ, Zhan Y, Isaak DD, Radosz M, Shen Y. Anticancer efficacies of cisplatin-releasing pH-responsive nanoparticles. Biomacromolecules. 2006:7:829-835.
18. Wong HL, Rauth AM, Bendayan R, Manias JL, Ramaswamy M, Liu Z, Erhan SZ, Wu XY. A new polymer-lipid hybrid nanoparticle system increases cytotoxicity of doxorubicin against multidrug-resistant human breast cancer cells. Pharm Res. 2006:23:1574-1585.
19. Soppimath KS, Tan DC-W, Yang Y-Y. pH-triggered thermally responsive polymer core-shell nanoparticles for drug delivery. Adv Mater. 2005:17:318-323.
20. Hruby M, Konak C, Ulbrich K. Polymeric micellar pH-sensitive drug delivery system for doxorubicin. J Control Release. 2005;103: 137-148.
21. Gao ZG, Lee DH, Kim DI, Bae YH. Doxorubicin loaded pH-sensitive micelle targeting acidic extracellular pH of human ovarian A2780 tumor in mice. J Drug Target. 2005:13:391-397.
22. Lee ES, Na K, Bae YH. Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor. J Control Release. 2005;103:405-418.
23. Liang H-F, Chen S-C, Chen M-C, Lee P-W, Chen C-T, Sung H-W. Paclitaxel-loaded poly(g-glutamic acid)-poly(lactide) nanoparticles as a targeted drug delivery system against cultured HEPG2 cells. Bioconjug Client. 2006;17;291-299.
24. Koziara JM, Whisman TR, Tseng MT, Mumper RJ. In-vivo efficacy of novel paclitaxel nanoparticles in paclitaxel-resistant human colorectal tumors. J Control Release. 2006;112:312-319.
25. Miura H, Onishi H, Sasatsu M, Machida Y. Antitumor characteristics of methoxypolyethylene glycol-poly(dl-lactic acid) nanoparticles containing camptothecin. J Control Release. 2004;97:101-113.
26. Williams J, Lansdown R, Sweitzer R, Romanowski M, LaBell R, Ramaswami R, Unger E. Nanoparticle drug delivery system for intravenous delivery of topoisomerase inhibitors. J Control Release. 2003:91:167-172.
27. Lamprecht A, Benoit JP. Etoposide nanocarriers suppress glioma cell growth by intracellular drug delivery and simultaneous p-glyco-protein inhibition, J Control Release. 2006;112:208-213.
28. Liu L, Li C, Li X, Yuan Z, An Y, He B. Biodegradable polylactide/ poly(ethylene glycol)/polylactide triblock copolymer micelles as anticancer drug carriers. J Appl Polym Sci. 2001;80:1976-1982.
29. Zhang L, Hu Y, Jiang X, Yang C, Lu W, Yang YH. Camptothecin derivative-loaded poly(caprolactone-co-lactide)-b-PEG-b-poly(caprolactone-co- lactide) nanoparticles and their biodistribution in mice. J Control Release. 2004;96:135-148.
30. Yoo HS, Lee K.H, Oh JE, Park TG. In vitro and in vivo anti-tumor activities of nanoparticles based on doxorubicin-PLGA conjugates. J Control Release. 2000;68:419-431.
31. Yokoyama M, Fukushima S, Uehara R, Okamoto K, Kataoka K, Sakurai Y, Okano T. Characterization of physical entrapment and chemical conjugation of adriamycin in polymeric micelles and their design for in vivo delivery to a solid tumor. J Control Release. 1998:50:79-92.
32. Kwon GS. Polymeric micelles for delivery of poorly water-soluble compounds. Crit Rev Therap Drug Carrier Syst. 2003;20: 357-403.
33. Laurand A, Laroche-Clary A, Larrue A, Huet S, Soma E, Bonnet J, Robert J. Quantification of the expression of multidrug resistance related genes in human tumor cell lines grown with free doxorubicin or doxorubicin encapsulated in polyisohexylcyanoacrylate nanospheres. Anticancer Res. 2004:24:3781-3788.
34. Rapoport N. Combined cancer therapy by micellar- encapsulated drug and ultrasound. Int J Pharm. 2004;277:155-162.
35. Aouali N, Morjani H, Trussardi A, Soma E, Giroux B, Manfait M. Enhanced cytotoxicity and nuclear accumulation of doxorubicinloaded nanospheres in human breast cancer MCF7 cells expressing MRP1. Int. J Oncol. 2003;23:1195-1201.
36. Vauthier C, Dubernet C, Chauvierre C, Brigger I, Couvreur P. Drug delivery to resistant tumors; the potential of poly(alkyl cyanoacrylate) nanoparticles. J Control Release.93:151-160, 2003.
37. Xu P, Van Kirk E, Zhan Y, Murdoch WJ, Radosz M, Shen Y. Targeted charge-reversal nanoparticles for nuclear drug delivery. Angew Chem Int Ed Engl. 2007;46:4999-5002.
38. Torchilin VP, Trubetskoy VS. Which polymers can make nanoparticulate drug carriers long-circulating? Adv Drug Deliv Rev. 1995;16; 141-155.
39. Vittaz M, Bazile D, Spenlehauer G, Verrecchia T, Veillard M, Puisieux F, Labarre D. Effect of PEO surface density on long-circulating PLA-PEO nanoparticles which are very low complement activators. Biomaterials. 1996:17:1575-1581.
40. De. Jaeghere F, Allemann E, Feijen JK, T., Doelker E, Gurny R. Cellular uptake of PEO surface-modified nanoparticles: evaluation of nanoparticles made of PLA: PEO diblock and triblock copolymers. J Drug Target. 2000;8;143-153.
41. Savic R, Luo L, Eisenberg A, Maysinger D. Micellar nanocontainers distribute to defined cytoplasmic organelles. Science. 2003:300:615-618.
42. Barret A, Heath M. Lysnsomes: a Laboratoiy Handbook, 2nd ed. New York: North-Holland, 1977.
43. Steinman RM, Mellman TS, Muller WA, Cohn ZA. Endocytosis and the recycling of plasma membrane. J Cell Biol. 1983;96;1-27.
44. Gong Y, Duvvuri M, Krise JP. Separate roles for the Golgi apparatus and lysosomes in the sequestration of drugs in the multidrug- resistant human leukemic cell line hl-60. J Biol Chem. 2003:278: 50234-50239.
45. Arancia G, Calcabrini A, Meschini S, Molinari A. Intracellular distribution of anthracyclines in drug resistant cells. Cytotechnology. 1998:27:95-111.
46. Engin K, Leeper DB, Cater JR, Thistlethwaite AJ, Tupchong L, McFarlane JD. Extracellular pH distribution in human tumours. Int J Hyperthermia. 1995;11:211-216.
47. Schmid S, Fuchs R, Kielian M, Helenius A, Mellman I. Acidification of endosome subpopulations in wild-type Chinese hamster ovary cells and temperature-sensitive acidification-defective mutants. J Cell Biol. 1989:108:1291-300.
48. Schmid SL, Fuchs R, Male P, Mellman I. Two distinct subpopulations of endosomes involved in membrane recycling and transport to lysosomes. Cell. 1988:52:73-83.
49. Reijngoud DJ, Tager JM. The permeability properties of the lysosomal membrane. Biochim Biophys Acta. 1977:472:419-449.
50. Lee ES, Na K, Bae YH. Super pH-sensitive multifunctional polymeric micelle. Nano Lett. 2005:5:325-329.
51. Xu P, Tang H, Li S-Y, Ren J, Van Kirk E, Murdoch WJ, Radosz M, Shen Y. Enhanced stability of core-surface cross-linked micelles fabricated from amphiphilic brush copolymers. Biomacromolecules. 2004:5:1736-1744.
52. Li X, Zuo J, Guo Y, Yuan X. Preparation and characterization of narrowly distributed nanogels with temperature-responsive core and pH-responsive shell. Macromolecules. 2004;37:10042-10046.
53. Verbaan FJ, Klouwenberg PK, van Steenis JH, Snel CJ, Boerman O, Hennink WE, Storm G. Application of poly(2-(dimethylamino)ethyl methacrylate)-based polyplexes for gene transfer into human ovarian carcinoma cells. Int J Pharm. 2005:304:185-192.
54. Wolf HK, de Raad M, Snel C, Steenbergen MJ, Fens MHAM, Storm G, Hennink WE. Biodegradable poly(2-dimethylamino ethylamino)-phosphazene for in vivo gene delivery to tumor cells. Effect of polymer molecular weight. Pharm Res. 2007;24;1572-1580.
55. Lee Hi, Jakubowski W, Matyjaszewski K, Yu S, Sheiko SS. Cylindrical core-shell brushes prepared by a combination of ROP and ATRP. Macromolecules. 2006:39:4983-4989.
56. You L, Lu F, Li Z, Zhang W, Li F. Glucose-sensitive aggregates formed by poly(ethylene oxide)-block-poly(2-glucosyl-oxyethyl acrylate) with concanavalin A in dilute aqueous medium. Macromolecules. 2003:36:1-4.
57. Lei L, Gohy J, Willet; N, Zhang J, Varshney S, Jérôme R. Tuning of the morphology of core-shell-corona micelles in water. I. Transition from sphere to cylinder. Macromolecules. 2004;37:1089-1094.
58. Hatefi A, Amsder B. Camptothecin delivery methods. Pharm Res. 2002;19:1389-1399.
59. Higuchi T. Mechanism of sustained action medication: theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci. 1963;52:1145-1149.
60. Murthy N, Robichaud JR, Tirrell DA, Stayton PS, Hoffman AS. The design and synthesis of polymers for eukaryotic membrane disruption. J Control Release. 1999:61:137-143.